Clinical Trial Update: A Study of VGL101 in Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia [Phase 2]

View source ↗

Summary

A Phase 2 trial of VGL101 for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia

Drugs mentioned

• VGL101

Snippet

Sponsor: Vigil Neuroscience, Inc. | Conditions: ALSP | Phase 2 | Status: TERMINATED